Myasthenia Gravis: Overview and Treatment
Myasthenia Gravis: Diagnostic Tests
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Autoimmune Disorders
Control System Problem
Combinatorial Gene Control
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Josefine Jul Jarbæk Nielsen1, Lotte Sahin Levison1, Henning Andersen1
1Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Individuals with myasthenia gravis (MG) have double the risk of developing other autoimmune diseases (ADs), particularly younger women. This suggests a common autoimmune susceptibility, impacting diagnosis and treatment strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: